Evidence mapPaperPMID 28870280Full record

ArticlePrimary health care research & development2018

Glucose and cholesterol stabilization in patients with type 2 diabetes mellitus with depressive and anxiety symptoms by problem-solving therapy in primary care centers in Mexico City.

Valerio Villamil-Salcedo, Blanca E Vargas-Terrez, Jorge Caraveo-Anduaga, Jorge González-Olvera, Adriana Díaz-Anzaldúa, José Cortés-Sotres, Magdalena Pérez-Ávila

Open access · hybridAbstract read
In one paragraph

Article in Primary health care research & development, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 15 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Observational
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Valerio Villamil-Salcedo1Investigator from Department of Clinical Investigations Branch,National Institute of Psychiatry Ramón de la Fuente Muñiz,Mexico City,Mexico.
Blanca E Vargas-Terrez2Chief of Community Psychiatry Service from the Clinical Services Branch,National Institute of Psychiatry Ramón de la Fuente Muñiz,Mexico City,Mexico.
Jorge Caraveo-Anduaga3Investigator from the Epidemiology and Psychosocial Investigations Branch,National Institute of Psychiatry Ramón de la Fuente Muñiz,Mexico City,Mexico.
Jorge González-Olvera4Head of the Clinical Investigations Branch,National Institute of Psychiatry Ramón de la Fuente Muñiz,Mexico City,Mexico.
Adriana Díaz-Anzaldúa5Investigator from Department of Genetics,Clinical Investigations Branch,National Institute of Psychiatry Ramón de la Fuente Muñiz,Mexico City,Mexico.
José Cortés-Sotres6Engineer, Department of Education,National Institute of Psychiatry Ramón de la Fuente Muñiz,Mexico City,Mexico.
Magdalena Pérez-Ávila7M.D. Physician from Department of Clinical Investigations Branch,National Institute of Psychiatry Ramón de la Fuente Muñiz,Mexico City,Mexico.
Instituto Nacional de Psiquiatría · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aim The aim of this study was to determine if the problem-solving therapy (PST) helps control metabolic variables in patients with type 2 diabetes mellitus (T2DM) who show depressive and anxiety symptoms.

backgroundT2DM is a chronic-degenerative multifactorial disease. It is considered one of the main public health problems in the world, and it represents an important social and economic burden. It is frequently associated with major depression and anxiety disorders, which are related with high glycated hemoglobin (HbA1c) concentrations and poor metabolic control.

methodWe initially included 123 patients diagnosed with T2DM from five primary care centers (PCC) in Mexico City. HbA1c, central glucose, and lipid profile were measured in each patient. In addition, the Kessler psychological distress scale (K-10), the Beck Depression Inventory, and the Beck Anxiety Inventory were applied at the beginning and, to those who continued, at the end of the PST, as well as four months later. Findings In total, 36 patients completed the PST and the follow-up. There was a significant decrease in depressive and anxiety symptoms (P<0.001), as well as in total cholesterol (P=0.002), HbA1c (P=0.05), and low-density lipoprotein (LDL) (P=0.022). The PST helps reduce depressive and anxiety symptoms and may help stabilize glucose and cholesterol up to four months. Further studies on this area are recommended. If our findings are confirmed, the PST could help improve the quality of life of thousands of individuals with psychiatric-metabolic co-morbidity who only visit PCC.

Indexed as

Anxiety DisordersBlood GlucoseCholesterolDepressive DisorderDiabetes Mellitus, Type 2FemaleHumansLongitudinal StudiesMaleMexicoMiddle AgedPrimary Health CareProblem SolvingPsychiatric Status Rating ScalesPsychotherapyTreatment OutcomeBlood GlucoseCholesterolcholesteroldepressiondiabetes mellitusglucose metabolism disordersprimary healthcare

Identifiers

PMID28870280
PMCPMC6452974
OpenAlexW2752917737

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.